The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD
Recruiting
N/A
Interventional Study
CVD - Cardiovascular Disease
Bruise
Pain
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 180 (estimated)
- Sponsor
- The Hong Kong Polytechnic University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day
* Chinese
Exclusion Criteria:
* cognitively impaired
* unconscious
* refuse to participate
Contacts